On December 28, 2018 Accuray Incorporated entered into an amendment to its credit and security agreement dated as of June 14, 2017, as previously amended and modified, by and among the company, as borrower, TomoTherapy Incorporated, a direct, wholly-owned subsidiary of the company, as borrower, any additional borrower that may be added thereto, Midcap Funding X Trust, individually as a lender and as agent, and the other lenders from time to time parties thereto and (ii) an amendment to its credit and security agreement dated as of December 15, 2017, as previously amended and modified, by and among the Borrowers, any additional borrower that may be added thereto, MidCap Financial Trust, individually as a lender and as agent, and the other lenders from time to time parties thereto. The Term Loan Amendment amended the Term Loan Agreement to, among other things, (i) provide a mechanism for determining an alternative interest rate to replace LIBOR upon the occurrence of certain circumstances, (ii) extend the Term Loan Tranche 2 Commitment Termination Date (as defined in the Term Loan Agreement) from December 31, 2018 until June 30, 2019, (iii) provide that Term Loan Tranche 2 may be drawn in two separate advances, and (iv) modify the calculation of the prepayment fee set forth in Section 2.2(g) of the Term Loan Agreement. The Revolving Loan Amendment amended the Revolving Credit Agreement to, among other things, (i) provide a mechanism for determining an alternative interest rate to replace LIBOR upon the occurrence of certain events and (ii) modify the calculation of the deferred revolving loan origination fee set forth in Section 2.2(g) of the Revolving Credit Agreement.